• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单羧基二胺二氯合铂(IV)配合物的选择性合成、表征和细胞毒性。

Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.

机构信息

University of Vienna, Institute of Inorganic Chemistry, Waehringer Strasse 42, A-1090, Vienna, Austria.

出版信息

Dalton Trans. 2011 Aug 28;40(32):8187-92. doi: 10.1039/c1dt10301f. Epub 2011 Jul 11.

DOI:10.1039/c1dt10301f
PMID:21743934
Abstract

(OC-6-43)-Dichlorido(N,N-dimethyl-ethane-1,2-diamine)dihydroxidoplatinum(IV) could selectively be mono-carboxylated with succinic anhydride based on the steric hindrance caused by the two methyl groups of the equatorial ligand. Subsequent esterification of the uncoordinated carboxylic acid with alcohols of different lengths (methanol, butanol, hexanol and octanol) afforded the corresponding esters. The synthesized complexes were characterized in detail by elemental analysis, ESI-MS, multinuclear ((1)H, (13)C, (15)N and (195)Pt) NMR spectroscopy and in two cases by X-ray crystallography. Cytotoxicity of novel platinum(IV) compounds was investigated in four human cancer cell lines (CH1, A549, SW480 and SK-OV-3). Remarkably, the most lipophilic complexes showed IC(50) values down to the low micromolar or even nanomolar range.

摘要

(OC-6-43)-二氯代(N,N-二甲基乙二胺)二羟基合铂(IV)可以根据配位体赤道位两个甲基的空间位阻选择性地与琥珀酸酐单羧化。随后,用不同长度的醇(甲醇、丁醇、己醇和辛醇)对未配位的羧酸进行酯化,得到相应的酯。通过元素分析、ESI-MS、多核(1H、13C、15N 和 195Pt)NMR 光谱以及两种情况下的 X 射线晶体学对合成的配合物进行了详细的表征。在四种人癌细胞系(CH1、A549、SW480 和 SK-OV-3)中研究了新型铂(IV)化合物的细胞毒性。值得注意的是,最亲脂性的配合物的 IC50 值低至低微摩尔甚至纳摩尔范围。

相似文献

1
Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.单羧基二胺二氯合铂(IV)配合物的选择性合成、表征和细胞毒性。
Dalton Trans. 2011 Aug 28;40(32):8187-92. doi: 10.1039/c1dt10301f. Epub 2011 Jul 11.
2
Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.具有极高细胞毒性的新型双(羧基)二氯(乙二胺)铂(IV)配合物。
J Inorg Biochem. 2008 Dec;102(12):2072-7. doi: 10.1016/j.jinorgbio.2008.07.006. Epub 2008 Jul 23.
3
Bulky N(,N)-(di)alkylethane-1,2-diamineplatinum(II) compounds as precursors for generating unsymmetrically substituted platinum(IV) complexes.作为生成不对称取代的铂(IV)配合物的前体,大体积的 N(,N)-(二)烷乙二胺铂(II)化合物。
Inorg Chem. 2013 Jul 15;52(14):8151-62. doi: 10.1021/ic400816g. Epub 2013 Jun 21.
4
Novel endothall-containing platinum(IV) complexes: synthesis, characterization, and cytotoxic activity.新型含烯草酮的铂(IV)配合物:合成、表征及细胞毒性活性。
Chem Biodivers. 2008 Oct;5(10):2160-2170. doi: 10.1002/cbdv.200890197.
5
Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.新型二羧酸和四羧酸铂(IV)配合物。合成、表征、细胞毒性活性及DNA铂化作用。
J Med Chem. 2007 Dec 27;50(26):6692-9. doi: 10.1021/jm070897b. Epub 2007 Nov 22.
6
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.新型双(羧基)二氯二乙胺合铂(IV)配合物的合成与表征,其细胞毒性高于顺铂。
Eur J Med Chem. 2011 Nov;46(11):5456-64. doi: 10.1016/j.ejmech.2011.09.006. Epub 2011 Sep 8.
7
Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.含混合轴向配体的双(羧基)和四(羧基)铂(IV)配合物——合成、表征及细胞毒性
Chem Biodivers. 2015 Apr;12(4):559-74. doi: 10.1002/cbdv.201400291.
8
Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.新型四羧酸根铂(IV)配合物作为卡铂前药。
Dalton Trans. 2012 Dec 21;41(47):14404-14415. doi: 10.1039/c2dt31366a.
9
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity.基于环己二胺和组蛋白去乙酰化酶抑制剂 2-(2-丙炔基)辛酸的铂(IV)配合物:合成、表征、细胞穿透特性和抗肿瘤活性。
Dalton Trans. 2021 Apr 7;50(13):4663-4672. doi: 10.1039/d0dt04135a. Epub 2021 Mar 16.
10
Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity.新型顺式和反式双(肟)铂(II)配合物的合成、表征及细胞毒性活性。
Inorg Chem. 2010 Jun 21;49(12):5669-78. doi: 10.1021/ic100584b.

引用本文的文献

1
Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform.负载铂(IV)的降解壳聚糖二醇作为高效的铂(IV)药物递送平台。
Pharmaceutics. 2023 Mar 24;15(4):1050. doi: 10.3390/pharmaceutics15041050.
2
The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo-A Comparison of O,O-, S,O-, and N,N-Chelate Effects.首例抗癌三(吡唑基)硼酸盐钼(IV)配合物:体外和体内试验- O,O-、S,O-和 N,N-螯合效应的比较。
Chemistry. 2020 Feb 17;26(10):2211-2221. doi: 10.1002/chem.201903605. Epub 2019 Nov 19.
3
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position.
轴向位置具有TSPO配体的首个奥沙利铂Pt(IV)衍生物的合成、表征及细胞毒性
Int J Mol Sci. 2016 Jun 25;17(7):1010. doi: 10.3390/ijms17071010.
4
Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.聚(有机)磷腈类大分子铂(IV)前药
Macromol Biosci. 2016 Aug;16(8):1239-1249. doi: 10.1002/mabi.201600035. Epub 2016 May 12.
5
Synthetic methods for the preparation of platinum anticancer complexes.铂类抗癌配合物的合成方法。
Chem Rev. 2014 Apr 23;114(8):4470-95. doi: 10.1021/cr4004314. Epub 2013 Nov 27.
6
Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery.马来酰亚胺功能化的铂(IV)配合物作为靶向药物传递的合成平台。
Chem Commun (Camb). 2013 Mar 18;49(22):2249-2251. doi: 10.1039/c3cc39258a.
7
Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.不对称的单核和双核铂(IV)配合物,具有乙二醇部分:合成、表征和生物活性。
J Med Chem. 2012 Dec 27;55(24):11052-61. doi: 10.1021/jm301645g. Epub 2012 Dec 17.
8
Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.二氨四(羧酸根)合铂(IV)配合物的合成、表征及细胞毒性。
Chem Biodivers. 2012 Sep;9(9):1840-8. doi: 10.1002/cbdv.201200019.